The neuraminidase of A(H3N2) influenza viruses circulating since 2016 is antigenically distinct from the A/Hong Kong/4801/2014 vaccine strain-Reference-Cited by-同舟云学术

The neuraminidase of A(H3N2) influenza viruses circulating since 2016 is antigenically distinct from the A/Hong Kong/4801/2014 vaccine strain

Published:2019-08-12 Issue:12 Volume:4 Page:2216-2225
ISSN:2058-5276
Container-title:Nature Microbiology
language:en
Short-container-title:Nat Microbiol

Author:

Wan Hongquan^ORCID,Gao Jin,Yang Hua,Yang Shuang,Harvey Ruth,Chen Yao-Qing,Zheng Nai-Ying,Chang Jessie,Carney Paul J.,Li Xing,Plant Ewan^ORCID,Jiang Lianlian,Couzens Laura,Wang Carol,Strohmeier Shirin,Wu Wells W.,Shen Rong-Fong,Krammer Florian^ORCID,Cipollo John F.,Wilson Patrick C.,Stevens James,Wan Xiu-Feng,Eichelberger Maryna C.,Ye Zhiping

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Microbiology (medical),Genetics,Applied Microbiology and Biotechnology,Immunology,Microbiology

Link

http://www.nature.com/articles/s41564-019-0522-6.pdf

Reference50 articles.

1. Kissling, E., Rondy, M. & I-MOVE/I-MOVE+ study team. Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe. Euro Surveill. 22, 30464 (2017).

2. Sullivan, S. G. et al. Low interim influenza vaccine effectiveness, Australia, 1 May to 24 September 2017. Euro Surveill. 22, 17-00707 (2017).

3. Paules, C. I., Sullivan, S. G., Subbarao, K. & Fauci, A. S. Chasing seasonal influenza—the need for a universal influenza vaccine. New Engl. J. Med. 378, 7–9 (2018).

4. Appiah, G. D. et al. Influenza activity—United States, 2014-15 season and composition of the 2015-16 influenza vaccine. MMWR Morb. Mortal. Wkly Rep. 64, 583-590 (2015).

5. Flannery, B. et al. Interim estimates of 2017-18 seasonal influenza vaccine effectiveness—United States, February 2018. MMWR Morb. Mortal. Wkly Rep. 67, 180–185 (2018).

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mosaic neuraminidase-based vaccine induces antigen-specific T cell responses against homologous and heterologous influenza viruses;Antiviral Research;2024-10

2. O-Glycosylated RNA Identification and Site-specific Prediction by Solid-phase Chemoenzymatic TnORNA method and PONglyRNA tool;2024-06-22

3. Constructing a Ready-to-Use mRNA Vaccine Delivery System for the Prevention of Influenza A virus, Utilizing FDA-Approved Raw Materials;Biomacromolecules;2024-06-06

4. Characteristics and evolution of hemagglutinin and neuraminidase genes of Influenza A(H3N2) viruses in Thailand during 2015 to 2018;PeerJ;2024-06-03

5. Capsid virus-like particle display improves recombinant influenza neuraminidase antigen stability and immunogenicity in mice;iScience;2024-06